What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His scientific interests lie mostly in Surgery, Sarcoma, Cancer, Survival rate and Soft tissue sarcoma.
His Surgery study incorporates themes from Radiology, Internal medicine and Metastasis.
His research integrates issues of Gastroenterology and Oncology in his study of Internal medicine.
The concepts of his Sarcoma study are interwoven with issues in Survival analysis, Radiation therapy and Soft tissue.
He has researched Survival rate in several fields, including Carcinoma, Univariate analysis, Stage, Colorectal cancer and Adenocarcinoma.
His Prospective cohort study research is multidisciplinary, relying on both Randomized controlled trial, Proportional hazards model and Clinical trial.
His most cited work include:
- Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer: Analysis of 1001 Consecutive Cases (2816 citations)
- Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. (2118 citations)
- Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. (1009 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Surgery, Internal medicine, Cancer, Sarcoma and Soft tissue sarcoma.
His Surgery study frequently intersects with other fields, such as Adenocarcinoma.
Murray F. Brennan combines subjects such as Pancreatic cancer and Pancreas with his study of Adenocarcinoma.
His work deals with themes such as Gastroenterology, Endocrinology and Oncology, which intersect with Internal medicine.
His study explores the link between Cancer and topics such as Surgical oncology that cross with problems in General surgery.
His Sarcoma research incorporates themes from Proportional hazards model and Primary tumor, Metastasis.
He most often published in these fields:
- Surgery (47.14%)
- Internal medicine (31.02%)
- Cancer (21.53%)
What were the highlights of his more recent work (between 2011-2021)?
- Surgery (47.14%)
- Cancer (21.53%)
- Internal medicine (31.02%)
In recent papers he was focusing on the following fields of study:
Murray F. Brennan mostly deals with Surgery, Cancer, Internal medicine, Sarcoma and Pathology.
His work in Surgery addresses issues such as Radiology, which are connected to fields such as Chemotherapy.
His Cancer research is multidisciplinary, incorporating perspectives in Stage, Surgical oncology and Family medicine.
His biological study spans a wide range of topics, including Gastroenterology and Oncology.
Murray F. Brennan studied Sarcoma and Soft tissue that intersect with Adult patients and Prognostic variable.
His Survival rate research is multidisciplinary, incorporating elements of Prospective cohort study, Carcinoma and Adjuvant therapy.
Between 2011 and 2021, his most popular works were:
- Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. (260 citations)
- Pasireotide for Postoperative Pancreatic Fistula (256 citations)
- Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. (246 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
The scientist’s investigation covers issues in Surgery, Internal medicine, Surgical oncology, Survival rate and Oncology.
His work carried out in the field of Surgery brings together such families of science as Nomogram and Sarcoma.
His Sarcoma research includes elements of Combined Modality Therapy, Proportional hazards model and Soft tissue.
In his study, which falls under the umbrella issue of Internal medicine, Lymph node is strongly linked to Gastroenterology.
His Surgical oncology research integrates issues from Cancer, Breast cancer, Pancreatic cancer, Neuroendocrine tumors and Stage.
The various areas that he examines in his Survival rate study include Prospective cohort study, Adjuvant therapy and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
